WO2007092416A3 - Melanin concentrating hormone receptor-1 antagonists - Google Patents
Melanin concentrating hormone receptor-1 antagonists Download PDFInfo
- Publication number
- WO2007092416A3 WO2007092416A3 PCT/US2007/003099 US2007003099W WO2007092416A3 WO 2007092416 A3 WO2007092416 A3 WO 2007092416A3 US 2007003099 W US2007003099 W US 2007003099W WO 2007092416 A3 WO2007092416 A3 WO 2007092416A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- present application
- application provides
- antagonists
- hormone receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Abstract
The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula (I) wherein R1a, R1b, R1c, Q, A, R3, W, D and R2 are defined herein. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07763593A EP1987039A2 (en) | 2006-02-06 | 2007-02-06 | Melanin concentrating hormone receptor-1 antagonists |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76553006P | 2006-02-06 | 2006-02-06 | |
US60/765,530 | 2006-02-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007092416A2 WO2007092416A2 (en) | 2007-08-16 |
WO2007092416A3 true WO2007092416A3 (en) | 2007-11-01 |
Family
ID=38284021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/003099 WO2007092416A2 (en) | 2006-02-06 | 2007-02-06 | Melanin concentrating hormone receptor-1 antagonists |
Country Status (3)
Country | Link |
---|---|
US (2) | US7553836B2 (en) |
EP (1) | EP1987039A2 (en) |
WO (1) | WO2007092416A2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8618115B2 (en) | 2005-10-26 | 2013-12-31 | Bristol-Myers Squibb Company | Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them |
WO2008039863A2 (en) * | 2006-09-27 | 2008-04-03 | Braincells, Inc. | Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders |
PE20091928A1 (en) * | 2008-05-29 | 2009-12-31 | Bristol Myers Squibb Co | HAVE HYDROXYSUSTITUTED PYRIMIDINES AS NON-BASIC MELANIN-CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS |
CN102245608A (en) | 2008-10-08 | 2011-11-16 | 百时美施贵宝公司 | Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
CN102245600A (en) * | 2008-10-08 | 2011-11-16 | 百时美施贵宝公司 | Pyrrolone melanin concentrating hormone receptor-1 antagonists |
CN102272135A (en) * | 2008-10-08 | 2011-12-07 | 百时美施贵宝公司 | Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
WO2010114896A1 (en) * | 2009-03-31 | 2010-10-07 | Arqule, Inc. | Substituted indolo-pyridinone compounds |
TR201910327T4 (en) | 2009-10-23 | 2019-07-22 | Janssen Pharmaceutica Nv | Di-substituted octahydropyrrolo [3,4-c] pyrroles as orexin receptor modulators. |
CA2794153C (en) | 2010-03-25 | 2018-01-02 | Glaxosmithkline Llc | Substituted indoline derivatives as perk inhibitors |
WO2012036233A1 (en) * | 2010-09-17 | 2012-03-22 | 塩野義製薬株式会社 | Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity |
KR101273643B1 (en) | 2010-10-12 | 2013-06-11 | 한국화학연구원 | 5,6-Dihydro-pyrrolo[3,4-b]pyridine-7-one derivatives, or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2683704B1 (en) | 2011-03-08 | 2014-12-17 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120054A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120055A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
JO3368B1 (en) * | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
JOP20150177B1 (en) | 2014-08-01 | 2021-08-17 | Janssen Pharmaceutica Nv | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
JP6861154B2 (en) | 2014-12-03 | 2021-04-21 | ヤンセン ファーマシューティカ エヌ.ベー. | Radiolabeled mGluR2 PET ligand |
EP3389728B1 (en) | 2015-12-18 | 2020-08-05 | Janssen Pharmaceutica NV | Radiolabelled mglur2/3 pet ligands |
LT3389727T (en) | 2015-12-18 | 2020-10-12 | Janssen Pharmaceutica Nv | Radiolabelled mglur2/3 pet ligands |
JP7066622B2 (en) | 2016-03-10 | 2022-05-13 | ヤンセン ファーマシューティカ エヌ.ベー. | How to treat depression with orexin-2 receptor antagonists |
TWI776812B (en) * | 2016-06-02 | 2022-09-11 | 荷蘭商菲林公司 | Angiotensin-1-receptor antagonists |
WO2024015425A1 (en) | 2022-07-14 | 2024-01-18 | Fmc Corporation | Herbicidal benzoxazines |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04297478A (en) * | 1991-02-21 | 1992-10-21 | Taiho Yakuhin Kogyo Kk | Substituted pyrroloimidazole derivative |
WO2003033480A1 (en) * | 2001-10-15 | 2003-04-24 | Smithkline Beecham Plc | Lactam derivatives as antagonists for human 11cby receptors |
WO2005042541A1 (en) * | 2003-10-23 | 2005-05-12 | Glaxo Group Limited | 3-(4-aminophenyl) thienopyrimid-4-one derivatives as mch r1 antagonists for the treatment of obesity, diabetes, depression and anxiety |
WO2005085221A1 (en) * | 2004-03-06 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3674836A (en) * | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
US4027009A (en) * | 1973-06-11 | 1977-05-31 | Merck & Co., Inc. | Compositions and methods for depressing blood serum cholesterol |
JPS5612114B2 (en) | 1974-06-07 | 1981-03-18 | ||
US3986140A (en) * | 1974-09-17 | 1976-10-12 | International Business Machines Corporation | 2,4,6 Trisubstituted pyridine dye lasers |
US3983836A (en) * | 1975-07-07 | 1976-10-05 | The Raymond Lee Organization, Inc. | Indicator bar for automobile radio |
JPS5432794A (en) | 1977-08-18 | 1979-03-10 | Omron Tateisi Electronics Co | Manufacturing method of terminal rack |
NO154918C (en) * | 1977-08-27 | 1987-01-14 | Bayer Ag | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF 3,4,5-TRIHYDROXYPIPERIDINE. |
US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
DE2951135A1 (en) * | 1979-12-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | SULFONYL UREAS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS AND THEIR USE |
DK149080C (en) * | 1980-06-06 | 1986-07-28 | Sankyo Co | METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES |
US4450171A (en) * | 1980-08-05 | 1984-05-22 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4448784A (en) * | 1982-04-12 | 1984-05-15 | Hoechst-Roussel Pharmaceuticals, Inc. | 1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof |
US5354772A (en) * | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
US4499289A (en) * | 1982-12-03 | 1985-02-12 | G. D. Searle & Co. | Octahydronapthalenes |
CA1327360C (en) | 1983-11-14 | 1994-03-01 | William F. Hoffman | Oxo-analogs of mevinolin-like antihypercholesterolemic agents |
US4613610A (en) * | 1984-06-22 | 1986-09-23 | Sandoz Pharmaceuticals Corp. | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives |
US4686237A (en) * | 1984-07-24 | 1987-08-11 | Sandoz Pharmaceuticals Corp. | Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof |
US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
DE3581638D1 (en) | 1984-12-04 | 1991-03-07 | Sandoz Ag | INDEN ANALOGA BY MEVALONOLAKTON AND THEIR DERIVATIVES. |
EP0221025A1 (en) | 1985-10-25 | 1987-05-06 | Sandoz Ag | Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals |
DE3543999A1 (en) * | 1985-12-13 | 1987-06-19 | Bayer Ag | HIGH PURITY ACARBOSE |
FR2596393B1 (en) | 1986-04-01 | 1988-06-03 | Sanofi Sa | HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM |
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
GR1000959B (en) | 1987-05-22 | 1993-03-16 | Squibb & Sons Inc | Phosphorus-containing hmg-coa reductase inhibitors new intermediates and method |
US4759923A (en) * | 1987-06-25 | 1988-07-26 | Hercules Incorporated | Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives |
JP2569746B2 (en) * | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | Quinoline mevalonolactones |
US4871721A (en) * | 1988-01-11 | 1989-10-03 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors |
US4924024A (en) * | 1988-01-11 | 1990-05-08 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors, new intermediates and method |
NO177005C (en) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogous process for the preparation of substituted pyridines, as well as intermediates for use in the preparation |
US5506219A (en) * | 1988-08-29 | 1996-04-09 | E. R. Squibb & Sons, Inc. | Pyridine anchors for HMG-CoA reductase inhibitors |
US5753675A (en) * | 1989-03-03 | 1998-05-19 | Novartis Pharmaceuticals Corporation | Quinoline analogs of mevalonolactone and derivatives thereof |
FI94339C (en) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Process for the preparation of pharmaceutically acceptable [R- (R *, R *)] - 2- (4-fluorophenyl) -, - dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl] -1H- for the preparation of pyrrole-1-heptanoic acid and its pharmaceutically acceptable salts |
US5177080A (en) * | 1990-12-14 | 1993-01-05 | Bayer Aktiengesellschaft | Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
JP2648897B2 (en) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | Pyrimidine derivatives |
DE4129603A1 (en) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
US5447954A (en) * | 1992-05-05 | 1995-09-05 | Smithkline Beecham P.L.C. | Phenylderivate as inhibitors of ATP citrate lyase |
US5712396A (en) * | 1992-10-28 | 1998-01-27 | Magnin; David R. | α-phosphonosulfonate squalene synthetase inhibitors |
LT3300B (en) | 1992-12-23 | 1995-06-26 | Schering Corp | Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor |
US5594016A (en) * | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
US5662934A (en) | 1993-01-05 | 1997-09-02 | Najarian; Thomas | Compositions and methods for lowering cholesterol while maintaining antioxidant levels |
CA2150372C (en) * | 1993-01-19 | 2002-08-20 | Nancy L. Mills | Stable oral ci-981 formulation and process of preparing same |
EP0733048A1 (en) | 1993-12-07 | 1996-09-25 | Smithkline Beecham Plc | Heterocyclic biphenylylamides useful as 5ht1d antagonists |
US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
US5488064A (en) * | 1994-05-02 | 1996-01-30 | Bristol-Myers Squibb Company | Benzo 1,3 dioxole derivatives |
US5385929A (en) * | 1994-05-04 | 1995-01-31 | Warner-Lambert Company | [(Hydroxyphenylamino) carbonyl] pyrroles |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5491134A (en) * | 1994-09-16 | 1996-02-13 | Bristol-Myers Squibb Company | Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives |
US5541204A (en) * | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
US5698527A (en) | 1995-08-08 | 1997-12-16 | Merck & Co., Inc. | Steroidal glycosides as antihyperlipidemic agents |
ATE344279T1 (en) | 1995-12-13 | 2006-11-15 | Univ California | CRYSTALS OF THE LIGAND-BINDING DOMAIN OF THE THYROID HORMONE RECEPTOR COMPLEXED WITH A LIGAND |
IL117702A0 (en) | 1996-03-28 | 1996-07-23 | Tel Aviv Medical Center Resear | Drug for hyperlipoproteinemia |
US5770615A (en) * | 1996-04-04 | 1998-06-23 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
DE19622222A1 (en) | 1996-06-03 | 1997-12-04 | Hoechst Ag | Use of sodium=proton exchange inhibitor |
WO1997048701A1 (en) | 1996-06-20 | 1997-12-24 | Pfizer Inc. | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
HRP970330B1 (en) | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
US6482821B2 (en) * | 1996-12-20 | 2002-11-19 | Hoechst Aktiengellschaft | Vitronectin receptor antagonists, their preparation and their use |
DE19653647A1 (en) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Vitronectin receptor antagonists, their preparation and their use |
DE19653645A1 (en) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Vitronectin receptor antagonists, their preparation and their use |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
PL336581A1 (en) | 1997-05-08 | 2000-07-03 | Agrevo Uk Ltd | Fungicides |
GB9713739D0 (en) | 1997-06-27 | 1997-09-03 | Karobio Ab | Thyroid receptor ligands |
ID23891A (en) | 1997-10-08 | 2000-05-25 | Sankyo Co | COMBINED JOINT HETEROSICLIC COMPOUNDS |
TR200100149T2 (en) | 1998-07-06 | 2001-10-22 | Bristol-Myers Squibb Company | Biphenyl-sulfonamides as dual angiotensin endothelin receptor antagonists |
AU5612199A (en) | 1998-09-10 | 2000-04-03 | Forbes Medi-Tech Inc. | Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other |
US6147089A (en) | 1998-09-17 | 2000-11-14 | Pfizer Inc. | Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines |
US6630178B1 (en) | 1998-11-25 | 2003-10-07 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
WO2000038722A1 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS |
GB9828442D0 (en) | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
ATE324106T1 (en) | 1999-02-24 | 2006-05-15 | Univ Johns Hopkins | COMPOSITIONS AND METHODS FOR REGULATING SERUM CHOLESTEROL |
AU5031200A (en) | 1999-05-28 | 2000-12-18 | Vertex Pharmaceuticals Incorporated | Method for preparing 5-substituted oxazoles |
US6414002B1 (en) * | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
PL365183A1 (en) | 2000-07-31 | 2004-12-27 | Smithkline Beecham P.L.C. | Carboxamide compounds and their use as antagonists of a human 11cby receptor |
JPWO2002101146A1 (en) | 2001-05-11 | 2004-10-14 | 阿里奈 中山 | Phosphorescent paper, method of manufacturing the same, and method of using the same |
CN1585751A (en) | 2001-10-25 | 2005-02-23 | 武田药品工业株式会社 | Quinoline compound |
MXPA05006569A (en) | 2002-12-20 | 2005-09-22 | Pharmacia Corp | Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds. |
MXPA05010859A (en) | 2003-04-11 | 2005-12-14 | Smithkline Beecham Corp | Heterocyclic mchr1 antagonists. |
RU2266906C1 (en) | 2004-04-29 | 2005-12-27 | Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") | Anellated carbamoyl azaheterocycles, methods for their preparing (variants), pharmaceutical composition, focused library |
US8618115B2 (en) * | 2005-10-26 | 2013-12-31 | Bristol-Myers Squibb Company | Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them |
-
2007
- 2007-02-05 US US11/671,150 patent/US7553836B2/en active Active
- 2007-02-06 WO PCT/US2007/003099 patent/WO2007092416A2/en active Application Filing
- 2007-02-06 EP EP07763593A patent/EP1987039A2/en not_active Withdrawn
-
2009
- 2009-05-15 US US12/466,639 patent/US7956049B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04297478A (en) * | 1991-02-21 | 1992-10-21 | Taiho Yakuhin Kogyo Kk | Substituted pyrroloimidazole derivative |
WO2003033480A1 (en) * | 2001-10-15 | 2003-04-24 | Smithkline Beecham Plc | Lactam derivatives as antagonists for human 11cby receptors |
WO2005042541A1 (en) * | 2003-10-23 | 2005-05-12 | Glaxo Group Limited | 3-(4-aminophenyl) thienopyrimid-4-one derivatives as mch r1 antagonists for the treatment of obesity, diabetes, depression and anxiety |
WO2005085221A1 (en) * | 2004-03-06 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds |
Non-Patent Citations (6)
Title |
---|
BECCALLI, EGLE M. ET AL: "Pd-catalyzed intramolecular cyclization of pyrrolo-2-carboxamides: regiodivergent routes to pyrrolo-pyrazines and pyrrolo-pyridines", TETRAHEDRON , 61(5), 1077-1082 CODEN: TETRAB; ISSN: 0040-4020, 2005, XP004714482 * |
CARPENTER A J ET AL: "Melanin-concentrating hormone receptor antagonists as potential antiob", EXPERT OPINION ON THERAPEUTIC PATENTS, ASHLEY PUBLICATIONS, GB, vol. 12, no. 11, 2002, pages 1639 - 1646, XP002318627, ISSN: 1354-3776 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1973, NOGUCHI, SHUNSAKU ET AL: "Pyrrole-1,2-dicarboxyimides", XP002444934, retrieved from STN Database accession no. 1973:84249 * |
KATRITZKY, ALAN R. ET AL: "Novel synthesis of bicycles with fused pyrrole, indole, oxazole, and imidazole rings", JOURNAL OF ORGANIC CHEMISTRY , 69(26), 9313-9315 CODEN: JOCEAH; ISSN: 0022-3263, 2004, XP002444929 * |
NEGORO T ET AL: "Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]p yrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.", JOURNAL OF MEDICINAL CHEMISTRY 8 OCT 1998, vol. 41, no. 21, 8 October 1998 (1998-10-08), pages 4118 - 4129, XP002444928, ISSN: 0022-2623 * |
PAPADOPOULOS, E. P.: "Reactions of pyrrole with isothiocyanates. Preparation and reactions of N-ethoxycarbonyylpyrrole-2-thiocarboxamide and 2-thiopyrrole-1,2-dicarboximide", JOURNAL OF ORGANIC CHEMISTRY , 38(4), 667-74 CODEN: JOCEAH; ISSN: 0022-3263, 1973, XP002444930 * |
Also Published As
Publication number | Publication date |
---|---|
US7956049B2 (en) | 2011-06-07 |
US7553836B2 (en) | 2009-06-30 |
US20070185097A1 (en) | 2007-08-09 |
EP1987039A2 (en) | 2008-11-05 |
US20090221548A1 (en) | 2009-09-03 |
WO2007092416A2 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007092416A3 (en) | Melanin concentrating hormone receptor-1 antagonists | |
WO2007050726A3 (en) | Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists | |
WO2009009501A3 (en) | Non-basic melanin concentrating hormone receptor-1 antagonists and methods | |
WO2008064107A3 (en) | 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods | |
MXPA05007857A (en) | Indole-derivative modulators of steroid hormone nuclear receptors. | |
TW200607807A (en) | Macrocyclic beta-secretase inhibitors | |
EA201001885A1 (en) | SYSTEM OF CONTROLLED DELIVERY | |
WO2004052847A3 (en) | Tricyclic steroid hormone nuclear receptor modulators | |
TW200621249A (en) | Substituted amide beta secretase inhibitors | |
EP1714961A4 (en) | Indazole compound and pharmaceutical use thereof | |
WO2007103295A3 (en) | Halogenated sulfonamide derivatives | |
WO2005080352A3 (en) | Quinazoline derivatives and therapeutic use thereof | |
WO2005063745A8 (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
WO2006124447A3 (en) | Substituted n-arylpyrrolidines as selective androgen receptor modulators | |
WO2010053861A3 (en) | Biologically active amides | |
WO2007144327A3 (en) | Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands | |
EA200970500A1 (en) | TETRAHYDROCYCLOPENT [b] INDOL COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS | |
WO2006081431A3 (en) | Compounds for treating inflammatory and demyelinating diseases | |
WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
NO20063329L (en) | Tricyclic steroid hormone nuclear receptor modulators | |
EP2607363A4 (en) | Fused ring compound for use as mineralocorticoid receptor antagonist | |
WO2010005580A3 (en) | Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity | |
WO2007114902A3 (en) | Alkylthiobenzylpiperidine compounds | |
WO2006078724A3 (en) | Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases | |
WO2008092072A3 (en) | Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007763593 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07763593 Country of ref document: EP Kind code of ref document: A2 |